Administration, Intranasal
"Administration, Intranasal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Delivery of medications through the nasal mucosa.
| Descriptor ID |
D000281
|
| MeSH Number(s) |
E02.319.267.120.655.500
|
| Concept/Terms |
Administration, Intranasal- Administration, Intranasal
- Intranasal Drug Administration
- Drug Administration, Intranasal
- Intranasal Administration
- Administrations, Intranasal
- Intranasal Administrations
- Administration, Intranasal Drug
- Administrations, Intranasal Drug
- Drug Administrations, Intranasal
- Intranasal Drug Administrations
- Administration, Nasal
- Administrations, Nasal
- Nasal Administration
- Nasal Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intranasal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intranasal".
This graph shows the total number of publications written about "Administration, Intranasal" by people in this website by year, and whether "Administration, Intranasal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
| 2025 | 0 | 1 | 1 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Intranasal" by people in Profiles.
-
Noronha IH, Wada LN, Rossetto BS, Moraschi BF, Ferreira CP, Santos Santana JK, do Valle RD, JĂșnior LCGP, Aristeu da Rosa J, Rosa DS, Kim Y, Lopes MF, Ribeiro DA, Gazzinelli RT, Bortoluci KR, Trossini GHG, Silveira ELV, de Vasconcelos JRC. Intranasal Vaccination With Recombinant Human Adenovirus Encoding trans-Sialidase Gene Protects Mice From Lethal Subcutaneous and Oral Trypanosoma cruzi Challenges. J Infect Dis. 2026 Sep 23; 234(3):449-461.
-
Zhang Y, Johansen MD, Ledger S, Shipley R, Zhao G, Moles E, Turville S, Thordarson P, Hansbro PM, Kavallaris M, Kelleher AD, Ahlenstiel CL. Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2. Drug Deliv Transl Res. 2026 Oct; 16(10):3848-3871.
-
Jaecklein E, Papavinasasundaram K, Ostroff GR, Sassetti C, Soto ER. Targeted delivery of antitubercular drugs using glucan lipid particles. Microbiol Spectr. 2025 Mar 04; 13(3):e0274424.
-
Goel H, Kalra V, Verma SK, Dubey SK, Tiwary AK. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. J Control Release. 2022 01; 341:782-811.
-
Sava V, Fihurka O, Khvorova A, Sanchez-Ramos J. Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration. Nanomedicine. 2020 02; 24:102119.
-
Afkhami S, Lai R, D'agostino MR, Vaseghi-Shanjani M, Zganiacz A, Yao Y, Jeyanathan M, Xing Z. Single-Dose Mucosal Immunotherapy With Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound After Antibiotic Cessation. J Infect Dis. 2019 09 13; 220(8):1355-1366.
-
Novak P, Pimentel Maldonado DA, Novak V. Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study. PLoS One. 2019; 14(4):e0214364.
-
Carrasquillo R, Chu K, Ramasamy R. Novel Therapy for Male Hypogonadism. Curr Urol Rep. 2018 Jun 09; 19(8):63.
-
Strathearn L, Kim S, Bastian DA, Jung J, Iyengar U, Martinez S, Goin-Kochel RP, Fonagy P. Visual systemizing preference in children with autism: A randomized controlled trial of intranasal oxytocin. Dev Psychopathol. 2018 05; 30(2):511-521.
-
Ramirez A, Co M, Mathew A. CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice. PLoS One. 2016; 11(3):e0150425.